Anzeige
Mehr »
Sonntag, 14.12.2025 - Börsentäglich über 12.000 News
Breaking News: Parazero Technologies und die Bundespolizei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
Sa2 Reasons to Buy Regeneron Stock Like There's No Tomorrow5
SaImmunityBio (IBRX) Climbs 7.76% on Europe Expansion4
SaLululemon, Biogen to exit Nasdaq 100 with Alnylam, Seagate among additions20
SaNeural Therapeutics mit Partner Hanf.com, MindMed und Tilray: Neue Chancen durch strengere Regeln im Cannabismarkt
SaFDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea6
SaAmgen CDR (CAD Hedged): Amgen CDR (CAD Hedged) declares dividend9
FrAlector Names Neil Berkley As Chief Financial Officer1
FrProthena Announces Board of Directors Update1
FrZevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)2
FrGSK beendet Partnerschaft: Ideaya Biosciences erhält Rechte für zwei Programme zurück4
FrAlector appoints Neil Berkley as chief financial officer1
FrArtiva Biotherapeutics, Inc. - 8-K, Current Report-
FrPaula Cobb steps down from Prothena's board to join Manifold Bio1
FrAnavex Life Sciences Corp.: Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease89NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments...
► Artikel lesen
FrAlector, Inc.: Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer75SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression...
► Artikel lesen
Fr4D Molecular Therapeutics, Inc.: 4DMT Announces New Employment Inducement Grants1
FrFDA endorses 2nd new gonorrhea treatment, clearing way for Innoviva's Nuzolvence2
FrProthena Corporation plc: Prothena Announces Board of Directors Update230Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced...
► Artikel lesen
Fr$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today1
FrAscendis Pharma gains amid takeover speculation1
Weiter >>